Skip to main content
An official website of the United States government
Government Funding Lapse
Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted.

The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov.

Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

Lactobacillus probiotic BSL_PS6

A probiotic composed of a strain of the Gram-positive, naturally-occurring bacterium Lactobacillus, with potential antimicrobial, immunomodulatory and protective activities. Upon oral administration of the Lactobacillus probiotic BSL_PS6, the Lactobacillus strain may improve digestion and help maintain adequate colonization of the gastrointestinal (GI) tract by modulating the composition of the normal microflora. During colonization of the GI tract, this bacterium adheres to human intestinal epithelial cells, and activates intestinal epithelial proliferation. This promotes the formation and maintenance of a protective barrier, thereby preventing the attachment of harmful pathogens. The Lactobacillus produces an acidic environment that is unfavorable for pathogens, thereby further protecting the intestinal mucosa against pathogen-induced damage and a loss of integrity of the intestinal mucosal barrier. Dietary supplementation with this bacterium may decrease intestinal inflammation and enhance intestinal immune responses.
Synonym:Lactobacillus supplement BSL_PS6
Lactobacillus-based probiotic BSL_PS6
Code name:BSL PS6
BSL_PS6
BSLPS6
Search NCI's Drug Dictionary